会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • CANCER MARKERS
    • 癌症标志
    • US20140051587A1
    • 2014-02-20
    • US14008182
    • 2012-03-30
    • Attila Lorincz
    • Attila Lorincz
    • C12Q1/68
    • C12Q1/6886C12Q2600/118C12Q2600/154
    • Hence, the invention relates to a method for diagnosis and/or prognosis of cancer, comprising the steps of analyzing in a sample of a subject the DNA methylation status of a genomic region of at least one member of the group of, (i) SFN according to SEQ ID NO. 1, (ii) SLIT2 according to SEQ ID NO. 2, (iii) SERPINB5 according to SEQ ID NO. 3; and (iv) TWIST 1 according to SEQ ID NO 4; wherein, if (i) SFN shows a methylation cut off value of above 80% and/or, (ii) SLIT2 shows a methylation cut-off value of above 45% and/or, (iii) SERPBINB5 shows a methylation cut-off value of above 70%, and/or (iv) TWIST 1 shows a methylation level below 15% the sample is categorized as a sample from a patient with cancer and/of a poor prognosis.
    • 因此,本发明涉及一种用于癌症的诊断和/或预后的方法,包括以下步骤:在受试者的样品中分析以下组中至少一个成员的基因组区域的DNA甲基化状态:(i)SFN 根据SEQ ID NO。 1,(ii)根据SEQ ID NO。 2,(iii)SEQ ID NO:5的SERPINB5。 3; 和(iv)根据SEQ ID NO 4的TWIST 1; 其中,如果(i)SFN显示高于80%的甲基化切断值和/或(ii)SLIT2显示高于45%的甲基化截止值和/或(iii)SERPBINB5显示甲基化截止值 值高于70%,和/或(iv)TWIST 1显示甲基化水平低于15%,样品被分类为患有癌症和/或预后不良的患者的样品。